UHRF1 and hepatocellular carcinoma: Furthermore, clinical samples from 58 patients with dysplastic nodules (n = 18) or HCC (n = 40) have shown an average of 20‐ and 40‐fold overexpression of UHRF1 in advanced and very advanced HCC cases.